Abstract
Objective
Study design
Results
Conclusion
Keywords
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Clinical EpidemiologyReferences
- GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables.Journal of clinical epidemiology. 2011; 64: 383-394
- Analysing data and undertaking meta-analyses.Cochrane handbook for systematic reviews of interventions. 2019; : 241-284
- Interpreting results and drawing conclusions.(editors)in: Higgins JPT Thomas J Chandler J Cumpston M Li T Page MJ Welch VA Cochrane Handbook for Systematic Reviews of Interventions version 6 (updated July 2019). Cochrane, 2019
- GRADE guidelines: 12. Preparing summary of findings tables-binary outcomes.Journal of clinical epidemiology. 2013; 66: 158-172
- Systematic reviews of observational studies of risk of thrombosis and bleeding in urological surgery (ROTBUS): introduction and methodology.Syst Rev. 2014; 3: 150
- A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results.Trials. 2015; 16: 495
- Uncertainties in baseline risk estimates and confidence in treatment effects.BMJ. 2012; 345: e7401
- Approach to outcome measurement in the prevention of thrombosis in surgical and medical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Chest. 2012; 141: 185-194https://doi.org/10.1378/chest.11-2289
- American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients.Blood Adv. 2019; 3: 3898-3944
- Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group.BMC Health Serv Res. 2004; 4: 38
- GRADE guidelines: 3. Rating the quality of evidence.Journal of clinical epidemiology. 2011; 64: 401-406
- Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise.CMAJ. 2014; 186: E123-E142
- GRADE guidelines: 2. Framing the question and deciding on important outcomes.Journal of clinical epidemiology. 2011; 64: 395-400
- A randomized multicenter trial to evaluate simple utility elicitation techniques in patients with gastroesophageal reflux disease.Med Care. 2004; 42: 1132-1142
- Development and use of health outcome descriptors: a guideline development case study.Health Qual Life Outcomes. 2020; 18: 167
- Rates of symptomatic venous thromboembolism in US surgical patients: a retrospective administrative database study.Journal of thrombosis and thrombolysis. 2009; 28: 458-464
- Expert Evidence in Guidelines G. Distinguishing opinion from evidence in guidelines.BMJ. 2019; 366: l4606
- Improving GRADE evidence tables part 3: detailed guidance for explanatory footnotes supports creating and understanding GRADE certainty in the evidence judgments.J Clin Epidemiol. 2016; 74 (Epub 6 Jan 12): 28-39https://doi.org/10.1016/j.jclinepi.2015.12.006
- Procedure-specific Risks of Thrombosis and Bleeding in Urological Cancer Surgery: Systematic Review and Meta-analysis.European urology. 2018; 73: 242-251
- Procedure-specific Risks of Thrombosis and Bleeding in Urological Non-cancer Surgery: Systematic Review and Meta-analysis.European urology. 2018; 73: 236-241
- Incidence of Venous Thromboembolism and Benefits and Risks of Thromboprophylaxis After Cardiac Surgery: A Systematic Review and Meta-Analysis.Journal of the American Heart Association. 2015; 4e002652
- Thromboembolic disease in spinal surgery: a systematic review.Spine. 2009; 34: 291-303
- The compliance of thromboprophylaxis affects the risk of venous thromboembolism in patients undergoing hip fracture surgery.SpringerPlus. 2016; 5: 1362
- The effect of aspirin and low-molecular-weight heparin on venous thromboembolism after knee replacement: a non-randomised comparison using National Joint Registry Data.J Bone Joint Surg Br. 2012; 94: 914-918https://doi.org/10.1302/0301-620X.94B7.29129
- The effect of aspirin and low-molecular-weight heparin on venous thromboembolism after hip replacement: a non-randomised comparison from information in the National Joint Registry.J Bone Joint Surg Br. 2011; 93 (10.302/0301-620X.93B11.27622): 1465-1470
- Venous thromboembolism after severe trauma: incidence, risk factors and outcome.Injury. 2010; 41: 97-101
- Incidence and timing of venous thromboembolism after surgery for gynecological cancer.Gynecol Oncol. 2011; 121 (Epub Dec 22): 64-69https://doi.org/10.1016/j.ygyno.2010.11.038
- Venous thromboembolism and use of prophylaxis among women undergoing laparoscopic hysterectomy.Obstet Gynecol. 2011; 117 (10.097/AOG.0b013e31821bdd16): 1367-1374
- Incidence and risk factors for symptomatic venous thromboembolism following cholecystectomy.Langenbeck's archives of surgery. 2015; 400: 463-469
- Interpreting GRADE's levels of certainty or quality of the evidence: GRADE for statisticians, considering review information size or less emphasis on imprecision?.Journal of clinical epidemiology. 2016; 75: 6-15
- Symptoms and clinical relevance: a dilemma for clinical trials on prevention of venous thromboembolism.Thromb Haemost. 2013; 109 (Epub 2013 Jan 24): 585-588https://doi.org/10.1160/TH12-08-0627
- Are asymptomatic DVTs relevant?: one measure for all.Chest. 2013; 143: 874https://doi.org/10.1378/chest.12-2510
- The COMET (Core Outcome Measures in Effectiveness Trials) Initiative.Maturitas. 2016; 91 (Epub Jun 9): 91-92https://doi.org/10.1016/j.maturitas.2016.06.007
Article info
Publication history
Footnotes
Conflict of interest: A.C. has served as a consultant for Synergy and his institution has received research support on his behalf from Alexion, Bayer, Novo Nordisk, Pfizer, Sanofi, Spark, and Takeda; all other authors declare no competing financial interests.
Funding: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.